Literature DB >> 20020311

The theoretical and experimental study on dicalcium phosphate dehydrate loading with protocatechuic aldehyde.

Yuehua Guo1, Shuxin Qu, Xiong Lu, Haodong Xie, Hongping Zhang, Jie Weng.   

Abstract

The aim of this study is to investigate the interaction between dicalcium phosphate dihydrate (CaHPO(4) x 2H(2)O, DCPD) and Protocatechuic aldehyde (C(7)H(6)O(3), Pca), which is the water-soluble constituents of Chinese Medicine, Salvia Miltiorrhiza Bunge (SMB), by calculating the absorption energy through molecular dynamics simulation. Furthermore, the effects of functional groups of Pca and temperature on Pca adsorbed by DCPD are calculated respectively. DCPD/Pca and DCPD were analyzed by X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR) and thermogravimetric analysis (TG). The simulation results showed that Pca mostly absorbed on the (0 2 0) surface of DCPD. The aldehyde group of Pca played a moren important role on the adsorption of Pca on DCPD than hydroxyl did, while temperature had no distinct effects on the adsorption. XRD results indicated that Pca induced the preferential growth of (0 2 0) crystal surface in DCPC/Pca whereas it had no influence on the crystal structure, the crystallinity and grain size of DCPD. FTIR and TG results showed that the characteristic peak of Pca was at 1295 cm(-1) and the content of Pca in DCPD was 16%, respectively. The present results show that molecular dynamics simulation is a very effective and complementary method to study the interaction between materials and medicine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20020311     DOI: 10.1007/s00894-009-0617-8

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  14 in total

Review 1.  Skeletal drug delivery systems.

Authors:  A K Jain; R Panchagnula
Journal:  Int J Pharm       Date:  2000-09-25       Impact factor: 5.875

Review 2.  Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements.

Authors:  M Bohner
Journal:  Injury       Date:  2000-12       Impact factor: 2.586

3.  Prevention of bone loss in ovariectomized rats: the effect of Salvia miltiorrhiza extracts.

Authors:  H J Chae; S W Chae; D H Yun; K S Keum; S K Yoo; H R Kim
Journal:  Immunopharmacol Immunotoxicol       Date:  2004-02       Impact factor: 2.730

4.  Molecular simulation of protein adsorption and desorption on hydroxyapatite surfaces.

Authors:  Jia-Wei Shen; Tao Wu; Qi Wang; Hai-Hua Pan
Journal:  Biomaterials       Date:  2007-11-07       Impact factor: 12.479

5.  Multi-component HPLC fingerprinting of Radix Salviae Miltiorrhizae and its LC-MS-MS identification.

Authors:  Ping Hu; Qiong-Lin Liang; Guo-An Luo; Zhong-Zhen Zhao; Zhi-Hong Jiang
Journal:  Chem Pharm Bull (Tokyo)       Date:  2005-06       Impact factor: 1.645

6.  The effect of the major components of Salvia Miltiorrhiza Bunge on bone marrow cells.

Authors:  Y R Liu; S X Qu; M F Maitz; R Tan; J Weng
Journal:  J Ethnopharmacol       Date:  2007-01-12       Impact factor: 4.360

Review 7.  Calcium phosphate cements as bone drug delivery systems: a review.

Authors:  M P Ginebra; T Traykova; J A Planell
Journal:  J Control Release       Date:  2006-06-05       Impact factor: 9.776

8.  Fabrication and evaluation of a new composite composed of tricalcium phosphate, gelatin, and Chinese medicine as a bone substitute.

Authors:  Chun-Hsu Yao; Hung-Ming Tsai; Yueh-Sheng Chen; Bai-Shuan Liu
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2005-11       Impact factor: 3.368

9.  Immobilization of Chinese herbal medicine onto the surface-modified calcium hydrogenphosphate.

Authors:  Feng-Huei Lin; Guo-Chung Dong; Ko-Shao Chen; George J Jiang; Chin-Wang Huang; Jui-Sheng Sun
Journal:  Biomaterials       Date:  2003-06       Impact factor: 12.479

10.  Adsorption mechanism of BMP-7 on hydroxyapatite (001) surfaces.

Authors:  Hailong Zhou; Tao Wu; Xiuli Dong; Qi Wang; Jiawei Shen
Journal:  Biochem Biophys Res Commun       Date:  2007-07-16       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.